Fujifilm Owns Japanese Drug Company Offering Influenza Drug As Potential Ebola Treatment

The New Yorker: How Fujifilm Came to the Ebola Fight
“…Japan said that Fujifilm was offering up the drug, Favipiravir, [which is made by Toyama Chemical, a company Fujifilm acquired five years ago,] as a potential stopgap in the fight against an outbreak of Ebola that has, according to the World Health Organization, killed nineteen hundred people in West Africa, and that Médecins Sans Frontières just called for a global military and civilian response to stop…” (Hunt, 9/5).